![](https://neuroclues.com/wp-content/uploads/2024/07/AD-300x200.webp)
Clinical highlights: Alzheimer’s Disease (AD)
The newsletter of this month will emphasize the latest research about Alzheimer’s Disease
Have a research question to share or an article to highlight?
A piece to write about neuroscience, eye tracking or neuroClues?
Let’s connect.
The newsletter of this month will emphasize the latest research about Alzheimer’s Disease
The newsletter of this month will emphasize the latest research about Progressive Supra Nuclear Palsy (PSP) as May is PSP Awareness month
Objective: to become the “stethoscope of the brain”
The newsletter of this month will make you discover 3 recent articles highlighting the relevance of eye tracking for Concussion, Alzheimer’s disease and Parkinson’s disease.
The newsletter of this month will emphasize the latest research about Spinocerebellar Ataxia
The newsletter of this month will emphasize the latest research about Parkinson’s disease (PD) as April is Parkinson’s Awareness month
The newsletter of this month is related to the relevance of eye tracking in Alzheimer’s disease
In summary P3Lab is one of the 78 companies selected among 1092 applicants by the European program EIC Accelerator. The funds will enable the company
The newsletter of this month is related to the relevance of eye tracking in Concussion
The newsletter of this month is related to the relevance of eye tracking in Deep Brain Stimulation (DBS) for Parkinson’s disease (PD).
neuroClues is powered by P3Lab SRL
VAT: BE 0750.746.841
Centre Monnet – Av. Jean Monnet, 1 –
1348 Louvain-la-Neuve – Belgium
iPeps Incubator – 187 rue Chevaleret – 75013 Paris – France
Our development is financed with
the support of the Walloon Region and the European Innovation Council
© Neuroclues 2022 – all rights reserved
Book a custom virtual walk-through of NeuroClues with one of our experts and see how our innovative eye-tracking technology could impact your clinical practice.